Hormone therapy associated with reduced colorectal cancer risk

The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news150616082.html">Hormone therapy associated with reduced colorectal cancer risk</a></p> <p>The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of <I>Cancer Epidemiology, Biomarkers and Prevention</I>, a journal of the American Association for Cancer Research.</p>